Trial Search Results

Blood and Marrow Transplant Clinical Research Network

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator: Blood and Marrow Transplant Clinical Trials Network

Intervention(s):

  • Drug: fluconazole
  • Drug: voriconazole
  • Procedure: bone marrow transplant
  • Drug: thalidomide
  • Drug: dexamethasone

Phase:

N/A

Eligibility


Criteria for entry into a study varies by protocol

Ages Eligible for Study

2 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting